Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1998-12-17
1999-12-28
Gerstl, Robert
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514376, 544408, 548181, 548183, 548226, C07D27734, A61K 31425
Patent
active
060082372
ABSTRACT:
Substituted 5-aryl-2,4-thiazolidinediones are potent agonists of PPAR, and are therefore useful in the treatment, control or prevention of diabetes, hyperglycemia, hyperlipidemia (including hypercholesterolemia and hypertriglyceridemia), atherosclerosis, obesity, vascular restenosis, and other PPAR .alpha., .delta. and/or .gamma. mediated diseases, disorders and conditions.
REFERENCES:
patent: 5342850 (1994-08-01), Ohnota et al.
patent: 5801173 (1998-09-01), Lohray et al.
J. Med. Chem. 1994, vol. 37, pp. 3977-3985 (Cantello, et al).
Current Pharm. Design, 1996, vol. 2, pp. 85-102 (Hulin, et al.).
Chem. Pharm. Bull. 30(10) pp. 3601-3616 (1982) Sohda, et al.
J. Med. Chem. 1996, vol. 39, pp. 665-668 Willson, et al.
Chem. Pharm. Bull 30(10) pp. 3580-3600 (1982) Sohda, et al.
J. Med. Chem. 1986, vol. 29, pp. 770-778 Schnur, et al.
Bergman Jeffrey
Boueres Julia K.
Desai Ranjit
Gratale Dominick F.
Han Wei
Gerstl Robert
McGinnis James L.
Merck & Co. , Inc.
Rose David L.
Yang Mollie M.
LandOfFree
Arylthiazolidinedione derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Arylthiazolidinedione derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Arylthiazolidinedione derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2382710